INS and diabetes mellitus: Diabetes mellitus (DM), a metabolic disorder characterized by dysregulation of blood sugar and insulin [1–3], has an estimated global prevalence of approximately 9% and is expected to affect 300–400 million worldwide by 2030 [4–10].